neu oncogene protein and epidermal growth factor receptor are independently expressed in benign and malignant breast tissues

Human Pathology

Volumn 21, Issue 7, 1990, Pages 750-758

  Tsutsumi, Yutaka ^a,b   Naber, Stephen P ^a,b   DeLellis, Ronald A ^a,b   Wolfe, Hubert J ^a,b   Marks, Paula J ^a,b   McKenzie, Sarah J ^a,b   Yin, Samuel ^a,b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BioNTech US   (United States)

Author keywords

breast carcinoma; epidermal growth factor receptor; immunohistochemistry; neu oncogene; normal breast

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

ARTICLE; BREAST TUMOR; FEMALE; HISTOCHEMISTRY; HISTOLOGY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; ONCOGENE NEU; PRIORITY JOURNAL;

BREAST; BREAST DISEASES; BREAST NEOPLASMS; COMPARATIVE STUDY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENES; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; SUPPORT, NON-U.S. GOV'T; TUMOR MARKERS, BIOLOGICAL;

EID: 0025307066     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/0046-8177(90)90035-4     Document Type: Article

References (58)

1. Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene
2. The neu gene: An erbB-homologous gene distinct from and unlinked to the gene encoding the EGF receptor
3. The neu oncogene encodes an epidermal growth factor receptor-related protein
4. Experimental approaches to hypothetical hormones: Detection of a candidate ligand of the neu protooncogene
5. Proto-oncogene abnormalities in human breast cancer: Correlations with anatomic features and clinical course of disease
6. Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene
7. Amplification of the neu (c-erbB-2) oncogene in human mammary tumors is relatively frequent and is often accompanied by amplification of the linked c-erbA oncogene
8. Alterations to either c-erbB-2 (neu) or c-myc proto-oncogenes in breast carcinomas correlate with poor short-term prognosis
9. Overexpression of the c-erbB-2 oncoprotein in human breast carcinomas: Immunohistological assessment correlates with gene amplification
10. Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading
11. Immunohistochemical localization of c-erbB-2 in human breast carcinomas
12. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer
13. Overexpression of the EGF receptor-related proto-oncogene erbB-2 in human mammary tumor cell lines by different molecular mechanisms
14. c-erbB-2 expression in benign and malignant breast disease
15. Immunohistochemical distribution of c-erbB-2 in infiltrating and in situ breast cancer
16. neu-protein overexpression in breast cancer. Association with comedotype ductal carcinoma in situ and limited prognostic value in stage II
17. Epidermal growth factor receptors and effect of epidermal growth factor on growth of human breast cancer cells in long-term tissue culture
18. Epidermal growth factor binding by breast tumour biopsies and relationship to oestrogen and progestin receptor levels
19. Characterisation of epidermal growth factor receptor and action on human breast cancer cells in culture
20. Epidermal growth factor receptors in human breast cancer
21. Epidermal growth factor requirement for development of cultured mammary gland
22. Epidermal-growth-factor receptor status as predictor of early recurrence of and death from breast cancer
23. Prognostic factors in breast cancer: Immunohistochemical staining for SPI and NCRC 11 related to survival, tumour epidermal growth factor receptor and oestrogen receptor status
24. Quantitative assays of epidermal growth factor receptor in human breast cancer: Cut-off points of clinical relevance
25. Epidermal growth factor receptor status of histological sub-types of breast cancer
26. Relationships between oestrogen receptor, epidermal growth factor receptor, ER-D5, and p24 oestrogen regulated protein in human breast cancer
27. Expression of epidermal growth factor receptors (EGFR) on breast carcinomas in relation to growth fractions, estrogen receptor status and morphological criteria. An immunohistochemical study
28. Epidermal growth factor receptor gene-amplified MDA-468 breast cancer cell line and its nonamplified variants
29. Amplification of the epidermal growth factor receptor gene in the BT20 breast carcinoma cell line
30. Multiple restriction fragment polymorphisms of the human epidermal growth factor receptor gene
31. Amplified and overexpressed epidermal growth factor receptor gene in uncultured primary human breast carcinoma
32. Epidermal growth factor receptor gene expression in estrogen receptor-positive and negative human breast cancer cell lines
33. Receptors for epidermal growth factor and steroid hormones in human breast cancer
34. Receptors for epidermal growth factor and insulin-like growth factor I and their relation to steroid receptors in human breast cancer
35. Specific expression of the pS2 gene in subclasses of breast cancers in comparison with expression of the estrogen and progesterone receptors and the oncogene ERBB2
36. An immunohistochemical evaluation of c-erbB-2 expression in human breast carcinoma
37. Estrogen regulation of epidermal growth factor receptor messenger ribonucleic acid
38. Progestin regulation of EGF-receptor mRNA accumulation in T-47D human breast cancer cells
39. A Mr = 190,000 glycoprotein phosphorylated on tyrosine residues in epidermal growth factor stimulated KB cells is the product of the c-erbB-2 gene
40. EGF binding to its receptor triggers a rapid tyrosine phosphorylation of the erbB-2 protein in the mammary tumor cell line SK-BR-3
41. Immunohistochemical detection of the neu protein in tissue sections of human breast tumors with amplified neu DNA
42. Strategies for the analysis of oncogene overexpression Studies of the neu oncogene in breast carcinoma
43. neu oncogene expression in benign breast tissues: A molecular and immunohistochemical analysis
44. Generation and characterization of monoclonal antibodies specific for the human neu oncogene product, p185
45. Monoclonal antiepidermal growth factor receptor antibodies which are inhibitors of epidermal growth factor binding and antagonists of epidermal growth factor-stimulated tyrosine protein kinase activity
46. Cellular localisation of human epidermal growth factor receptor
47. Use of avidin-biotin-complex (ABC) in immunoperoxidase techniques A comparison between ABC and unlabeled antibody (PAP) procedures
48. Epidermal growth factor receptors in lung tumours
49. Immunohistochemical localization of the epidermal growth factor receptor in normal human tissues
50. Electron microscopic evidence for epidermal growth factor receptor (EGFR)-like immunoreactivity associated with the basolateral surface of gastric parietal cells
51. Epidermal growth factor regulates the expression of its own receptor
52. Epidermal growth factor (EGF) stimulates EGF receptor synthesis
53. Biphasic effects of type β transforming growth factor on epidermal growth factor receptors in NRK fibroblasts
54. Modulation of epidermal growth factor receptor gene expression by transforming growth factor-β in a human breast carcinoma cell line
55. Hyperproduction and gene amplification of the epidermal growth factor receptor in squamous cell carcinomas
56. Expression of epidermal growth factor receptors on human cervical, ovarian and vulval carcinomas
57. Epidermal growth factor receptor expression in human foetal tissues is age-dependent
58. Epidermal growth factor receptor in meningiomas is expressed predominantly on endothelial cells